SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.

SenesTech Stock Down 8.8 %

SenesTech stock opened at $2.19 on Monday. SenesTech has a fifty-two week low of $1.90 and a fifty-two week high of $9.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32. The firm’s 50-day simple moving average is $3.01 and its 200 day simple moving average is $2.84. The stock has a market cap of $2.26 million, a PE ratio of -0.22 and a beta of 0.09.

SenesTech (NASDAQ:SNES) last issued its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million. Research analysts predict that SenesTech will post -10.22 EPS for the current fiscal year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.